Norges Bank’s Terns Pharmaceuticals TERN Stock Holding History

Norges Bank’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-395,205	Closed	-$16M	–	1259
2025 Q4	$16M	Buy	+395,205	New	+$9.13M	﹤0.01%	1247
2025 Q1	–	Sell	-849,389	Closed	-$4.71M	–	1846
2024 Q4	$4.71M	Buy	+849,389	New	+$5.75M	﹤0.01%	1514
2024 Q2	–	Sell	-137,100	Closed	-$899K	–	1984
2024 Q1	$899K	Sell	137,100 -289,600	-68%	-$1.89M	﹤0.01%	1804
2023 Q4	$2.77M	Hold	426,700	–	–	﹤0.01%	1766
2023 Q3	$2.15M	Buy	426,700 +262,800	+160%	+$1.67M	﹤0.01%	1818
2023 Q2	$1.43M	Buy	+163,900	New	+$1.91M	﹤0.01%	1898
2021 Q2	–	Sell	-23,068	Closed	-$507K	–	2256
2021 Q1	$507K	Buy	+23,068	New	+$506K	﹤0.01%	2089

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank's TERN Position: Q1 2026 in Review

Norges Bank sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 395,205 shares — an estimated $16M sold.

Norges Bank first reported a position in TERN in Q1 2021 and held it in 7 quarters. The position peaked at $16M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Norges Bank reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 395,205 Terns Pharmaceuticals shares in Q1 2026, an estimated $16M.
Norges Bank first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 7 quarters.
Norges Bank's Terns Pharmaceuticals position peaked at $16M in Q4 2025.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.